跳至主要内容
临床试验/NCT05596539
NCT05596539招募中不适用

Prospective, Longitudinal, Observational Registry of Adult Patients With Hypophosphatasia

Assistance Publique - Hôpitaux de Paris22 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2023年3月22日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
200
试验地点
22
主要终点
Characterise the circumstances of diagnosis, and deduce ways to reduce the diagnostic delay of hypophosphatasia in adults.

研究概览

简要总结

The purpose of this study is to assess medical events during follow-up of adult patients having hypophosphatasia and consulting rheumatologists.

详细描述

Hypophosphatasia (HPP) is a rare inherited disease caused by mutations of the ALPL gene. In adult HPP, patients may suffer from fractures, pseudofractures, fracture healing complications, osteoarthritis, chondrocalcinosis, dental diseases, muscle pain and disability, but also headache, muscle weakness, ocular disease, and other symptoms. In some cases the diagnosis is severely delayed. Moreover a number of patients having such symptoms and a low level of serum alkaline phosphatase, without gene mutation can be followed by rheumatologists with difficulties in management of bone fragility and pain. The aim of this register is to describe prospectively the medical events in adult patients having hypophosphatasia, whether or not there is a proven genetic abnormality.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • men and women,
  • aged 18 and over, with no upper age limit, who have had a total alkaline phosphatase value of less than 40 IU/l on at least 3 occasions, or at least a total alkaline phosphatase value below 40 IU/L and evidence of ALPL gene polymorphism
  • with at least one rheumatological symptom.

排除标准

  • transient hypophosphatasia: absence of confirmation of a value below 40 IU/l on at least 3 samples, lack of genetic confirmation
  • secondary hypophosphatasia according to the expert rheumatologist (drugs, endocrine disease, other genetic disease...).

结局指标

主要结局

Characterise the circumstances of diagnosis, and deduce ways to reduce the diagnostic delay of hypophosphatasia in adults.

时间窗: At inclusion

Time since first symptom due to hypophosphatasia

次要结局

  • Characterise the forms for which the genetic analysis is negative(At inclusion)
  • Recognise situations of associated osteoporosis.(At 72 months)
  • Characterise "non bony" forms: chondrocalcinosis, multiple tendon calcifications, inflammatory pseudo-rheumatism, odonto-HPP(At inclusion)
  • Characterise the practical follow-up of asfotase alpha treatment started in adults(At 72 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (22)

Loading locations...

相似试验